Form 4 for MGX Metagenomi Therapeutics, Inc.
Accepted 2025-12-08 00:00:00 ET · period of report 2025-12-05 · accession 0001193125-25-310971 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-08 | 2025-12-05 | MGX | Thomas Brian C. | Dir | S - Sale | $1.77 | -3,830 | 2.51M | -0.2% | -$6,779 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-05 | S | D | 3,830 | $1.77 | 2,510,960 | D | — | — |